» Articles » PMID: 35854107

The Serotonin Theory of Depression: a Systematic Umbrella Review of the Evidence

Overview
Journal Mol Psychiatry
Date 2022 Jul 19
PMID 35854107
Authors
Affiliations
Soon will be listed here.
Abstract

The serotonin hypothesis of depression is still influential. We aimed to synthesise and evaluate evidence on whether depression is associated with lowered serotonin concentration or activity in a systematic umbrella review of the principal relevant areas of research. PubMed, EMBASE and PsycINFO were searched using terms appropriate to each area of research, from their inception until December 2020. Systematic reviews, meta-analyses and large data-set analyses in the following areas were identified: serotonin and serotonin metabolite, 5-HIAA, concentrations in body fluids; serotonin 5-HT receptor binding; serotonin transporter (SERT) levels measured by imaging or at post-mortem; tryptophan depletion studies; SERT gene associations and SERT gene-environment interactions. Studies of depression associated with physical conditions and specific subtypes of depression (e.g. bipolar depression) were excluded. Two independent reviewers extracted the data and assessed the quality of included studies using the AMSTAR-2, an adapted AMSTAR-2, or the STREGA for a large genetic study. The certainty of study results was assessed using a modified version of the GRADE. We did not synthesise results of individual meta-analyses because they included overlapping studies. The review was registered with PROSPERO (CRD42020207203). 17 studies were included: 12 systematic reviews and meta-analyses, 1 collaborative meta-analysis, 1 meta-analysis of large cohort studies, 1 systematic review and narrative synthesis, 1 genetic association study and 1 umbrella review. Quality of reviews was variable with some genetic studies of high quality. Two meta-analyses of overlapping studies examining the serotonin metabolite, 5-HIAA, showed no association with depression (largest n = 1002). One meta-analysis of cohort studies of plasma serotonin showed no relationship with depression, and evidence that lowered serotonin concentration was associated with antidepressant use (n = 1869). Two meta-analyses of overlapping studies examining the 5-HT receptor (largest n = 561), and three meta-analyses of overlapping studies examining SERT binding (largest n = 1845) showed weak and inconsistent evidence of reduced binding in some areas, which would be consistent with increased synaptic availability of serotonin in people with depression, if this was the original, causal abnormaly. However, effects of prior antidepressant use were not reliably excluded. One meta-analysis of tryptophan depletion studies found no effect in most healthy volunteers (n = 566), but weak evidence of an effect in those with a family history of depression (n = 75). Another systematic review (n = 342) and a sample of ten subsequent studies (n = 407) found no effect in volunteers. No systematic review of tryptophan depletion studies has been performed since 2007. The two largest and highest quality studies of the SERT gene, one genetic association study (n = 115,257) and one collaborative meta-analysis (n = 43,165), revealed no evidence of an association with depression, or of an interaction between genotype, stress and depression. The main areas of serotonin research provide no consistent evidence of there being an association between serotonin and depression, and no support for the hypothesis that depression is caused by lowered serotonin activity or concentrations. Some evidence was consistent with the possibility that long-term antidepressant use reduces serotonin concentration.

Citing Articles

Investigating the association between night eating symptoms and chronotype: the mediating role of depressive symptoms in a sample of Italian university students.

Riccobono G, Barlattani T, Socci V, Trebbi E, Iannitelli A, Pompili A Eat Weight Disord. 2025; 30(1):25.

PMID: 40088328 DOI: 10.1007/s40519-024-01707-y.


Major depressive disorder on a neuromorphic continuum.

Li J, Long Z, Ji G, Han S, Chen Y, Yao G Nat Commun. 2025; 16(1):2405.

PMID: 40069198 PMC: 11897166. DOI: 10.1038/s41467-025-57682-0.


Neuropsychiatric Abnormalities in Metabolic Disturbances: Interplay of Adipokines and Neurotransmission.

Cheon S, Song J Mol Neurobiol. 2025; .

PMID: 40042730 DOI: 10.1007/s12035-025-04797-6.


Editorial: Community series in early life stress and depression, Volume II.

Wang F, Yang J, Pan F, Bourgeois J, Huang J Front Psychiatry. 2025; 16:1408329.

PMID: 40034181 PMC: 11873562. DOI: 10.3389/fpsyt.2025.1408329.


Benchmarking macaque brain gene expression for horizontal and vertical translation.

Luppi A, Liu Z, Hansen J, Cofre R, Niu M, Kuzmin E Sci Adv. 2025; 11(9):eads6967.

PMID: 40020056 PMC: 11870082. DOI: 10.1126/sciadv.ads6967.


References
1.
Coppen A . The biochemistry of affective disorders. Br J Psychiatry. 1967; 113(504):1237-64. DOI: 10.1192/bjp.113.504.1237. View

2.
Cowen P, Browning M . What has serotonin to do with depression?. World Psychiatry. 2015; 14(2):158-60. PMC: 4471964. DOI: 10.1002/wps.20229. View

3.
Harmer C, Duman R, Cowen P . How do antidepressants work? New perspectives for refining future treatment approaches. Lancet Psychiatry. 2017; 4(5):409-418. PMC: 5410405. DOI: 10.1016/S2215-0366(17)30015-9. View

4.
Yohn C, Gergues M, Samuels B . The role of 5-HT receptors in depression. Mol Brain. 2017; 10(1):28. PMC: 5483313. DOI: 10.1186/s13041-017-0306-y. View

5.
Hahn A, Haeusler D, Kraus C, Hoflich A, Kranz G, Baldinger P . Attenuated serotonin transporter association between dorsal raphe and ventral striatum in major depression. Hum Brain Mapp. 2014; 35(8):3857-66. PMC: 6868983. DOI: 10.1002/hbm.22442. View